News

Additionally, improving CAR-T biological efficiency could reduce dosing needs, further cutting costs and expanding access.
America’s largest carmaker is now also one of its biggest battery companies. It aims to beat Tesla on battery costs this year ...
Following CORDStrom TM, INmune Bio plans to transition production of INKmune ®, its NK-priming cell medicine for solid tumors, to the same facility, supporting ongoing and future trials in the US and ...
Dublin, April 04, 2025 (GLOBE NEWSWIRE) -- The "Cell Therapy Manufacturing Market Industry Trends and Global Forecasts to 2035, by Type of Cell Therapy, Source of Cells, Scale of Operation ...
Enovix (ENVX) announced the acquisition of battery cell manufacturing assets from SolarEdge (SEDG), located in South Korea. The acquisition ...
One researchers explained that bacteria do a really, really good job of keeping the sequence you want and the sequence that you get.
INmune Bio partners with UK-based Catapult to enhance cell therapy manufacturing for the production of its cell therapies.
Cell therapy, a treatment that involves transferring living cells into a patient to help restore function or fight disease, shows great potential for treating diseases such as cancers, inflammatory ...
Premier Energies has partnered with Germany-based RENA Technologies for next-generation solar cell technologies. The collaboration will focus on optimising wet chemical processes for N-Type solar ...
ACME Group is targeting Rs 10,000 crore revenue from solar module and solar cell manufacturing business by 2030.
Acquisition will support company’s efforts to meet growing demand in the defense industryFREMONT, Calif., April 03, 2025 (GLOBE NEWSWIRE) -- Enovix Corporation (Nasdaq: ENVX), a global ...